Intra-cellular therapies to present at the 2023 cantor fitzgerald global healthcare conference

New york, sept. 20, 2023 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that it will present at the 2023 cantor fitzgerald global healthcare conference on wednesday, september 27, 2023 at 1:15 p.m. et.
ITCI Ratings Summary
ITCI Quant Ranking